Swahili
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Metabolic Imprints of Alcoholic Beverages

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
Kiungo kimehifadhiwa kwenye clipboard
HaliImekamilika
Wadhamini
University of Copenhagen
Washirika
Carlsberg Foundation

Maneno muhimu

Kikemikali

Metabolic imprints of five different types of alcohol will be investigated in two study groups.
The study will be an assessor-blinded, parallel dietary trial (crossover design).
The project aims to identify the chemical nature and kinetics of metabolite changes related to alcohol, hops, grapes and other beverage constituents as well as the brewing processes.

Maelezo

Metabolic imprints of five different types of alcohol will be investigated in two study groups of 15 participants in each with equal distribution of gender, occasional (0-2 u/week) and habitual drinkers (>2 u/week), respectively.

The intervention is divided into two periods: abstaining and drinking period. Occasional drinkers begin the abstaining intervention and habitual drinkers begin the drinking intervention, and cross-over after 3 weeks.

In the drinking period women consume 1 unit/day and men 2 units/day.

Study participants will consume five different types of alcohol; beer, cider, white wine, red wine and spirits. The sequence of alcohol consumption in the drinking period is randomized by 'random number allocation'.

Study participants are asked to collect 24h urine samples three days in beginning of each intervention and one day in the end of last intervention. The remaining days of the trial they are asked to make a urine spot test each morning at home. Beside urine samples, they are to give blood samples on each trial day and at screening (6 times). Overnight-fasting blood samples are drawn at day 0, 1 and 21, 22 and 42 of the six week intervention and one at screening before intervention.

Furthermore, participants receive kits to provide a dry blood sampling the following three days after trial days in situ. There will also be taken blood pressure and questionnaire handouts. A voluntary hair sample will be taken at Baseline (day 0) and final day of intervention (day 42).

From these samples the following will be determined:

1. dehydroepiandrosterone sulphate (DHEAS) and related (steroid) hormones and metabolites (primary hypothesis is a sustained increase in DHEAS following alcohol intake)

2. cresol, cresol sulphate, indoxyl sulphate and indole acetic acid (human microbial co-metabolites)

3. humulone-derived conjugates and several analogues and unidentified metabolites from the intake of raw materials from beverage production, including hops, malt, cider apples and grapes etc. (by explorative methods)

4. malt- or brewing-related unidentified metabolites (by explorative methods)

5. additional markers of wine and strong liquor intake (by explorative methods)

6. investigating the use of sampling urine and blood on filter papers and the feasibility of collecting small hair samples

7. investigating metabolic markers in relation to blood pressure, heart rate, physical activity, blood lipids, fibrinogen, adiponectin, and psychosocial well-being etc. after 3 weeks light to moderate alcohol intake or abstaining.

8. metabolic profiling of urine, blood and hair to explore contrasts between periods of drinking and abstaining or periods with specific alcoholic beverages.

Tarehe

Imethibitishwa Mwisho: 11/30/2017
Iliyowasilishwa Kwanza: 12/10/2017
Uandikishaji uliokadiriwa Uliwasilishwa: 12/21/2017
Iliyotumwa Kwanza: 12/26/2017
Sasisho la Mwisho Liliwasilishwa: 12/21/2017
Sasisho la Mwisho Lilichapishwa: 12/26/2017
Tarehe halisi ya kuanza kwa masomo: 01/12/2016
Tarehe ya Kukamilisha Msingi iliyokadiriwa: 11/30/2016
Tarehe ya Kukamilisha Utafiti: 11/30/2017

Hali au ugonjwa

Metabolic Side Effects of Drugs and Substances

Uingiliaji / matibabu

Dietary Supplement: Drinking

Other: Abstaining

Awamu

-

Vikundi vya Arm

MkonoUingiliaji / matibabu
Experimental: Drinking
Occasional drinkers assigned to start with a 3week drinking period (women 1 u/day - men 2 u/day) Followed by crossover without washout to 3 week abstaining period
Experimental: Abstaining
Habitual drinkers assigned to start 2 weeks of abstaining from alcohol Followed by crossover without washout to 3 weeks drinking (women 1 u/day - men 2 u/day)

Vigezo vya Kustahiki

Zama zinazostahiki Kujifunza 20 Years Kwa 20 Years
Jinsia Inastahiki KujifunzaAll
Hupokea Wajitolea wa AfyaNdio
Vigezo

Inclusion Criteria:

- 20 years of age

- No intolerance of alcohol

- Experience with alcohol

- Able to use smartphone or tablet

Exclusion Criteria:

- Serious chronic health conditions or psychiatric diseases

- Chronic intake of medicine (beside birth control and SSRI)

- Alcohol and/or drug abuse assessed AUDIT score >4 (AUDIT = Alcohol Use Disorders Identification Test).

- Blood samples/donations during trial and 3 months prior

- Liver dysfunction

- High risk of breast cancer assessed by BCRAT score (BCRAT = The Breast Cancer Risk Assessment Tool)

- Pregnancy or lactating

Matokeo

Hatua za Matokeo ya Msingi

1. DHEAS [3 weeks]

Changes in dehydroepiandrosterone sulphate (DHEAS) and related (steroid) hormones and metabolites

Hatua za Matokeo ya Sekondari

1. Markers of alcohol intake [3 weeks]

Ethyl glucuronide, ethyl sulphate, fatty acid ethyl esters, phosphatidyl ethanol and any other ethanol metabolite

2. Human microbial co-metabolites [3 weeks]

Cresol, cresol sulphate, indoxyl sulphate and indole acetic acid

3. Markers of intake of raw materials from the beverage productions [1 day]

Humulone-derived conjugates and several analogues and unidentified metabolites from the intake of raw materials used in beverage production, including hops, malt, cider apples, grapes, unknown metabolites from processing, etc.

4. Metabolites from outcomes 1-4 measured in dry urine spots [1 day]

Investigating the use of sampling urine on cotton sticks

5. Metabolites from outcomes 1-4 measured in dry blood samples [1 day]

Investigating the use of sampling blood on filter papers

6. Metabolites from outcomes 1-4 measured in a hair sample [3 weeks (1 day)]

Investigating the feasibility of collecting small hair samples before and after trial

7. Blood pressure [1d - 3 weeks]

Investigating changes in blood pressure and heart rate from beginning to end of each intervention period.

8. Physical activity monitoring [1d - 3weeks]

Investigating changes in physical activity from beginning to end of each intervention period using a chip with a 3D-gyro mounted on the thigh to record movements during periods of 24-72 hours at the beginning and end of the intervention periods.

9. Blood lipids [3 weeks]

Investigating changes in blood lipids at the end of each intervention period

10. Fibrinogen [3 weeks]

Investigating changes in fibrinogen and related coagulation factors at the end of each intervention period

11. Adiponectin [3 weeks]

Investigating changes in adiponectin at the end of each intervention period

12. Psychosocial well-being [3 weeks]

Investigating changes in psycho-social well-being using a standardized questionnaire at the beginning and end of each intervention period.

Hatua Nyingine za Matokeo

1. Discriminant metabolic profiles [3 weeks]

Metabolic profiles of blood, urine or hair discriminating periods of alcohol drinking and abstaining determined by receiver-operator characteristics of prediction models provided by partial least squares discriminant analyses comparing random training and test sets.

2. Discriminant metabolic profiles [4-5 days]

Metabolic profiles of dry urine spots discriminating periods of drinking specific alcoholic beverages (beer, cider, red wine, white wine or spirits) with abstaining determined by receiver-operator characteristics of prediction models provided by partial least squares discriminant analyses comparing random training and test sets.

Jiunge na ukurasa
wetu wa facebook

Hifadhidata kamili ya mimea ya dawa inayoungwa mkono na sayansi

  • Inafanya kazi katika lugha 55
  • Uponyaji wa mitishamba unaungwa mkono na sayansi
  • Kutambua mimea kwa picha
  • Ramani ya GPS inayoshirikiana
  • Soma machapisho ya kisayansi yanayohusiana na utafutaji wako
  • Tafuta mimea ya dawa na athari zao
  • Panga maslahi yako na fanya tarehe ya utafiti wa habari, majaribio ya kliniki na ruhusu

Andika dalili au ugonjwa na usome juu ya mimea ambayo inaweza kusaidia, chapa mimea na uone magonjwa na dalili ambazo hutumiwa dhidi yake.
* Habari zote zinategemea utafiti wa kisayansi uliochapishwa

Google Play badgeApp Store badge